Altitude Crest Partners Inc. has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $234 Billion distributed in 30 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Legend Biotech Corp with a value of $36.6B, Danaher Corp with a value of $27.1B, Bridge Bio Pharma, Inc. with a value of $18.9B, Stevanato Group S.P.A. with a value of $17.7B, and Apellis Pharmaceuticals, Inc. with a value of $16.9B.
Examining the 13F form we can see an increase of $84.1B in the current position value, from $149B to 234B.
Altitude Crest Partners Inc. is based out at Stamford, CT
Below you can find more details about Altitude Crest Partners Inc. portfolio as well as his latest detailed transactions.